California stem cell agency directors are in the midst of a discussion of changes in their strategic planto focus more heavily on driving reseach into treatments.
Ellen Feigal, vice president of research and development, introduced the discussion and noted that the agency does not plan to abandon basic research, a touchy subject for many researchers. She also said the directors should examine the proportion of expenditures devoted to basic research and translational research.
No comments:
Post a Comment